|

Cerebellar Mutism Syndrome Study

RECRUITINGSponsored by Rigshospitalet, Denmark
Actively Recruiting
SponsorRigshospitalet, Denmark
Started2014-10
Est. completion2028-12-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02300766

Summary

The purpose of this study is to determine why up to 25% of the pediatric patients who have surgery for a tumor in the posterior fossa develops the Cerebellar Mutism Syndrome (CMS). Furthermore the purpose is to explore the clinical course and the best treatment of the syndrome.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Age \< 18 years at the date of first imaging showing this tumour
* Tumour in the cerebellum/4th ventricle/brainstem with intention to treat with surgical resection or open biopsy. Second and further surgeries are also included.
* Informed consent from custodial parent(s)

Exclusion Criteria:

* None

Conditions3

CancerInfratentorial NeoplasmsMutism

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.